Latest edition of the Journal of Neuromuscular Diseases now online – Sep 2020
A new issue of the Journal of Neuromuscular Diseases has recently been released. Read it below:
Journal of Neuromuscular Diseases: Volume 7, issue 4
*NMD4C lead investigator Hanns Lochmüller is joint editor-in-chief of the Journal of Neuromuscular Diseases, together with Carsten Bönnemann of the NIH National Institute of Neurological Disorders and Stroke.
Articles in this issue:
- Towards central nervous system involvement in adults with hereditary myopathies
- Induction of skeletal muscle progenitors and stem cells from human induced pluripotent stem cells
- Lower extremity muscle involvement in the intermediate and Bethlem myopathy forms of COL6-related dystrophy and Duchenne muscular dystrophy: A cross-sectional study
- Ganglionopathies associated with MERRF syndrome: An original report
- Respiratory dysfunction in Becker muscular dystrophy patients: A case series and autopsy report
- Decision-making and selection bias in four observational studies on Duchenne and Becker muscular dystrophy
- Phenotypic spectrum of myopathies with recessive anoctamin-5 mutations
- Natural history of type 1 spinal muscular atrophy in a series of Argentinian children
- Neuroanatomical models of muscle strength and relationship to ambulatory function in spinal muscular atrophy
- Facilitators and barriers to wearing hand orthoses by adults with Duchenne muscular dystrophy: A mixed methods study design
- Identification and characterization of splicing defects by single-molecule real-time sequencing technology (PacBio)
- Swallowing, chewing, and speaking: Frequently impaired in oculopharyngeal muscular dystrophy
- Correlation between quantitative MRI and muscle histopathology in muscle biopsies from healthy controls and patients with IBM, FSHD, and OPMD
- A new point mutation in the PMP22 gene in a family suffering from atypical HNPP
- Severe inflammatory myopathy in a pulmonary carcinoma patient treated with Pembrolizumab: An alert for myologists
- Familial oculo-leptomeningeal transthyretin amyloidosis caused by Leu55Arg mutation
- Taking a Strohl through history: Putting Strohl back in Guillain-Barré-Strohl syndrome
- Measuring outcomes in adults with spinal muscular atrophy: Challenges and future directions – Meeting report
Read next...
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.